|
|
San Francisco , California June 24, 2008
ARX (Algorithmic Research), a leading provider of digital signatures (standard electronic signatures) that ensure document integrity, announced today that CoSign®, its digital signature solution, has been certified by SAFE-BioPharma™. CoSign is the most widely used digital signature technology in the BioPharma industry.
"This advancement not only enables companies to implement the strong user authentication put forth by SAFE-BioPharma, but also eliminates tokens, smartcards, and proprietary software, for substantial cost savings of 75 to 90 percent," said Rodd Schlerf, Life Sciences and Healthcare Manager, ARX.
CoSign's centralized digital signature (PKI-based) design enables the signer’s credentials to be accessed centrally from any network or web portal in any location. In addition to the speed and security with which digital signatures can be obtained, CoSign establishes a legally-binding audit trail.
"CoSign's certification provides the level of confidence SAFE-BioPharma members seek in implementing SAFE-BioPharma solutions. This is truly a win-win development for both ARX and SAFE-BioPharma," said Mollie Shields-Uehling, President and CEO, SAFE-BioPharma Association.
By agreeing to SAFE-BioPharma’s credentialing standards, pharmaceutical companies reduce the cost and duration of business processes, speeding product development. |
|
About SAFE-BioPharma
SAFE-BioPharma Association is the non-profit association that created and manages the SAFE-BioPharma™ digital identity and signature standard for the pharmaceutical and healthcare industries. The SAFE-BioPharma industry standard is used to mitigate legal, regulatory and other business risk associated with business-to-business and business-to-regulator electronic transactions. It facilitates interoperability by providing a secure, enforceable, and regulatory-compliant way to verify identities of parties involved in electronic transactions. SAFE-BioPharma’s vision is to be a catalyst in transforming the biopharmaceutical and healthcare communities to a fully electronic business environment by 2012. The Association’s members include Amgen (NASDAQ: AMGN), AstraZeneca (NYSE: AZN), Bristol-Myers Squibb (NYSE:BMY), Genzyme (NASDAQ: GENZ), GlaxoSmithKline (NYSE: GSK), Johnson & Johnson (NYSE: JNJ), Merck (NYSE:MRK), Pfizer (NYSE: PFE), Procter & Gamble (NYSE: PG), Roche and Sanofi-Aventis (NYSE:SNY).
|
|
About CoSign Digital Signatures
ARX (Algorithmic Research) is a global provider of cost-efficient digital signature solutions for industries such as AEC, life sciences, healthcare, government, energy, and manufacturing. ARX CoSign® is the market leading digital signature solution. CoSign digital signatures fully automate signature-dependent processes affordably and compliantly, allowing organizations to go paperless and save time and money. Compatible with major document types including Word, Excel®, PDF, PDF/A, and IBM Forms, CoSign signatures are globally verifiable without requiring proprietary validation software. CoSign is also centrally managed by your organization for reliable control over signature privileges. Learn more about the CoSign digital signature solution.
|
|
About ARX - The Digital Signature Company
ARX (Algorithmic Research) is a global provider of cost-efficient digital signature solutions for industries such as life sciences, healthcare, government, engineering, and energy. ARX engineers and scientists have more than 20 years of experience in security and standard digital signature applications. ARX helps businesses secure, streamline, and scale their processes and transactions with the proper controls required by legislation, regulation, and industry best practices. Learn more about us.
|
|
###
CoSign is a registered trademark of Algorithmic Research, Ltd. All other trade names and trademarks are the property of their respective holders.
|
|
|
|
|
|
|
|
